1st Quarter - Report

THE DUBERSTEIN GROUP INC. for PHRMA INC.

Firm
Client
Income
$100,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Sustainable growth rate and impact on other Medicare programs, Medicare physician payment, budget offsets - HR 3630, Temporary Payroll Tax Cut Continuation Act of 2011.

LobbyistCovered position, as disclosed
MICHAEL BERMAN —
STEVEN CHAMPLIN —
KENNETH DUBERSTEIN —
BRIAN GRIFFIN —
DANIEL P MEYER —
MARTI THOMAS —
ERIC UELAND —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 3630 (112th)

Health Issues HCR

Repeal Independent Payment Advisory Board provision of PL 111-148, PL 111-152 - HR 452, Medicare Decisions Accountability Act of 2011; HR 5, Protecting Access to Healthcare Act; S 2118, Health Care Bureaucrats Elimination Act. FDA user fee agreements - Proposed legislation re this issue.

LobbyistCovered position, as disclosed
MICHAEL BERMAN —
STEVEN CHAMPLIN —
KENNETH DUBERSTEIN —
BRIAN GRIFFIN —
DANIEL P MEYER —
MARTI THOMAS —
ERIC UELAND —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 452 (112th), H.R. 5 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.